IP Law Podcast: Christopher Loh of Fitzpatrick Cella Harper & Scinto in New York City discusses the Amgen v. Sanofi CAFC decision and his paper “End of ‘well characterized antigen’ test?”

November 6, 2018

 

The International Intellectual Property Law Podcast

Episode 49

Christopher Loh of Fitzpatrick Cella Harper & Scinto in New York City discusses the Amgen v. Sanofi CAFC decision and his paper “End of ‘well characterized antigen’ test?”

Click here to listen.

 

 

 

 

   

Featured

Donald M. Cameron Donald M. Cameron
B.A.Sc. (Eng. Sci.), M.A.Sc. (Aerospace), LL.B.
Partner